0001140361-11-049967.txt : 20111021 0001140361-11-049967.hdr.sgml : 20111021 20111020175753 ACCESSION NUMBER: 0001140361-11-049967 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20111021 DATE AS OF CHANGE: 20111020 EFFECTIVENESS DATE: 20111021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDVENTIVE INC CENTRAL INDEX KEY: 0001376460 IRS NUMBER: 205537609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-167634 FILM NUMBER: 111150863 BUSINESS ADDRESS: STREET 1: 400 FIFTH AVENUE STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 290-2500 MAIL ADDRESS: STREET 1: 400 FIFTH AVENUE STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0704 D LIVE 0001376460 MEDVENTIVE INC 400 FIFTH AVENUE SUITE 200 WALTHAM MA MASSACHUSETTS 02451 (781) 290-2500 DELAWARE None None Corporation true Nancy Ham 400 Fifth Street Suite 200 Waltham MA MASSACHUSETTS 02451 Executive Officer Director President and Chief Executive Officer Jonathan Niloff 400 Fifth Avenue Suite 200 Waltham MA MASSACHUSETTS 02451 Director Executive Officer Chief Technology Officer Peter Grua c/o HLM Venture Partners Fund II, L.P. 222 Berkeley Street, 21st Floor Boston MA MASSACHUSETTS 02116 Director Enrico Petrillo c/o Prudential Tower 800 Boylston Street, Suite 1585 Boston MA MASSACHUSETTS 02199 Director Mark Levine c/o Core Capital Partners 1401 I Street, N.W., Suite 1000 Washington DC DISTRICT OF COLUMBIA 20005 Director Nancy Brown 400 Fifth Avenue Suite 200 Waltham MA MASSACHUSETTS 02451 Executive Officer Director Chief Growth Officer Mark Collins 400 Fifth Avenue Suite 200 Waltham MA MASSACHUSETTS 02451 Executive Officer Chief Financial Officer, Treasurer and Secretary Charles Baker 400 Fifth Avenue Suite 200 Waltham MA MASSACHUSETTS 02451 Director Other Health Care Decline to Disclose 06 false 2011-08-25 false true true false 2083 900000 900000 0 Convertible Promissory Notes and Warants to purchase Series C Preferred Stock false 9 0 0 0 false MEDVENTIVE INC /s/ Mark Collins Mark Collins Chief Financial Officer, Treasurer, and Secretary 2011-10-20